Skip to content
Opens in a new window
S2026 Ep10: Balancing Topical Steroids in the Era of Nonsteroidals
15 October 2026

S2026 Ep10: Balancing Topical Steroids in the Era of Nonsteroidals

Don't Be Rash®: The Official Podcast of the Society for Pediatric Dermatology

About

Lawrence Eichenfield, MD, professor of dermatology and pediatrics at UC San Diego and chief of pediatric dermatology at Rady Children's Hospital, joins host Andrew C. Krakowski, MD, his former trainee, for a deep look at topical corticosteroids in children. Eichenfield discusses how social media has fueled steroid phobia, even though true topical steroid withdrawal is rare. He explains how potency depends on the molecule, its concentration, and its vehicle. For example, the same steroid can change potency class between an ointment and a cream, and clobetasol is vastly stronger than hydrocortisone despite similar-looking percentages. The conversation covers once- vs twice-daily dosing, prescribing by quantity, and when frequent maintenance use signals a switch to a nonsteroidal agent. Eichenfield also reviews matching potency to body site, the special case of lichen sclerosus, and where roflumilast, tapinarof, ruxolitinib, and delgocitinib now fit, along with the insurance hurdles that still shape prescribing.

Don't Be Rash is produced by Dermatology Times in collaboration with the Society for Pediatric Dermatology. Learn more at pedsderm.net. Have a topic you think we should cover? Email DTeditor@mmhgroup.com to join the conversation.